Former Pfizer executive probed on alleged Covid vaccine delay - CNN

Published 30/06/2025, 21:02
Former Pfizer executive probed on alleged Covid vaccine delay - CNN

Investing.com -- The House Judiciary Committee has issued a subpoena to Dr. Philip Dormitzer, a former Pfizer (NYSE:PFE) executive, as part of its investigation into allegations that the company deliberately delayed Covid-19 vaccine testing until after the 2020 presidential election, CNN reports.

According to documents obtained by CNN Monday, the committee subpoenaed Dormitzer after he reportedly failed to comply with requests to appear voluntarily and provide records.

Dormitzer is described as a central figure in the legislative investigation. The committee alleges it has information that Dormitzer, after joining British drugmaker GSK, told colleagues that Pfizer had delayed announcing its Covid vaccine’s effectiveness until after the election.

Dormitzer has publicly denied any delay in seeking approval for the vaccine.

The subpoena demands both documents and a deposition from the former Pfizer executive as the committee continues its investigation.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.